BRISTLECONE ADVISORS, LLC – Neurocrine Biosciences, Inc. Transaction History
BRISTLECONE ADVISORS, LLC portfolio value:
$392,000
portfolio value
BRISTLECONE ADVISORS, LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.87% | 32 shares | 35K | $106.21 | 3.69K |
| Q2 2022 | share | Decrease | -37.43% | -2.18K shares | -191K | $97.48 | 3.66K |
| Q1 2022 | share | Increase | +18.14% | 898 shares | 126K | $93.75 | 5.84K |
| Q4 2021 | share | Increase | +31.33% | 1.18K shares | 60K | $84.63 | 4.95K |
| Q3 2021 | share | Increase | +13.35% | 444 shares | 38K | $95.91 | 3.77K |
| Q2 2021 | share | Increase | +2.62% | 85 shares | 9K | $97.32 | 3.32K |
| Q1 2021 | share | Increase | +26.31% | 675 shares | 69K | $97.25 | 3.24K |
| Q4 2020 | share | Increase | 0.00% | 2.56K shares | 246K | $95.85 | 2.56K |